Delivery Order SPE2DB25D3012-SPE2DB26FWVTZ
- Not listed
- The Defense Logistics Agency awarded a $20,829.15 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for Refresh Plus 0.5% eye drops (30-count units). This is a firm fixed-price, competitively awarded contract with a completion date of September 15, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The contract specifies performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $1,125.76 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Refresh Plus 0.5% eye drops (30-unit package). This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The contract specifies Conshohocken, Pennsylvania as the place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,243.20 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on July 24, 2025, with completion targeted for July 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Refresh Plus 0.5% eye drops in 30-unit quantities. This $1,540.57 firm fixed-price contract represents a non-competitive delivery order utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded under the broader IDC vehicle (SPE2DX) valued at $999,999,999.00 and expiring in December 2026, which...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Refresh Plus 0.5% eye drops in unit dose format (50 units) valued at $2,397.84. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $1,911.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Refresh Plus 0.5% eye drops (30-count units). This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (70 count unit dose) on October 16, 2025, with a ceiling value of $1,214.81 and an ultimate completion date of October 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical supply transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,395.77 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on September 26, 2025, with completion scheduled for September 29, 2025. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply delivery under the company's existing federal contract vehicle with DLA. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,044.04 to AmerisourceBergen Drug Corp for the supply of Refresh Plus 0.5% eye drops in 30-unit quantities. This is a firm fixed price, non-competitive delivery order that was awarded on October 16, 2025, with an ultimate completion date of October 17, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $2,845.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) with a completion date of September 17, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB26FWVTZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Refresh Plus 0.5% eye drops in unit dose 50-count packages. This firm fixed price delivery order, valued at $2,155.74, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award is unset-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order reflects AmerisourceBergen's role as a critical vendor within the DLA's pharmaceutical supply chain, providing medical commodities to support military healthcare programs worldwide. As a prime contractor under the comprehensive Pharmaceutical Prime Vendor Global Program, the company supplies an extensive portfolio of pharmaceutical products and medical supplies to customers including the Defense Health Agency and U.S. Coast Guard. The award demonstrates the company's capability to fulfill federal medical supply requirements through competitive procurement, consistent with its track record of delivering various medications and medical supplies across multiple therapeutic domains to defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 11/4/25 |